Ionis Pharmaceuticals Files 8-K on Financials
Ticker: IONS · Form: 8-K · Filed: Apr 29, 2026 · CIK: 0000874015
| Field | Detail |
|---|---|
| Company | Ionis Pharmaceuticals Inc (IONS) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
TL;DR
IONIS dropped an 8-K on 4/29/26 with financial results. Check it out.
AI Summary
Ionis Pharmaceuticals, Inc. filed an 8-K on April 29, 2026, reporting results of operations and financial condition. The filing includes financial statements and exhibits, with the primary document being an iXBRL 8-K filing.
Why It Matters
This filing provides investors with updated financial information and operational results for Ionis Pharmaceuticals, Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any unusual risks or events.
Key Players & Entities
- IONIS PHARMACEUTICALS INC (company) — Filer
- 0000874015 (company) — CIK number for Ionis Pharmaceuticals Inc.
- 2026-04-29 (date) — Filing Date
FAQ
What specific financial results are reported in this 8-K filing?
The filing indicates Item 2.02: Results of Operations and Financial Condition, but the specific details of the results are contained within the attached exhibits.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-29 at 07:00:32.
What are the main document types included in this filing?
The filing includes an iXBRL 8-K, Exhibit 99.1, and a graphic image file.
Where is Ionis Pharmaceuticals, Inc. located?
The company's mailing and business address is 2855 GAZELLE COURT, CARLSBAD CA 92010.
What is the SIC code for Ionis Pharmaceuticals, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2026 regarding IONIS PHARMACEUTICALS INC (IONS).